AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10192108 — intervention group
Group type: COMPARATOR
Intervention: Reference preparation (enteric soluble formulation containing 36 mg peppermint oil and 20 mg caraway oil)
Number of subjects: 223
Study 10192108 — intervention group
Group type: EXPERIMENTAL
Intervention: Test preparation
Number of subjects: 223
Study 10192108 — intervention group
Group type: EXPERIMENTAL
Intervention: Both preparations
Number of subjects: 223
Study 7766746 — intervention group
Group type: COMPARATOR
Intervention: Ispaghula, 3.5 g twice a day
Number of subjects: 8
Study 7766746 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin, 250 mg t.d.s. per os
Number of subjects: 8
Study 7766746 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 8
Study 1980220 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 50 micrograms twice daily
Number of subjects: 20
Study 1980220 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 100 micrograms twice daily
Number of subjects: 20
Study 1980220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7026400 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 16
Study 7026400 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31177240 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized sitting balance measurements (eyes-open)
Number of subjects: 60
Study 31177240 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized sitting balance measurements (eyes-closed)
Number of subjects: 60
Study 31177240 — intervention group
Group type: EXPERIMENTAL
Intervention: Function in Sitting Test (FIST)
Number of subjects: 60
Study 31177240 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized sitting balance measurements
Number of subjects: 60
Study 31177240 — intervention group
Group type: COMPARATOR
Intervention: Clinical sitting balance measurement (FIST)
Number of subjects: 60
Study 29870855 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT-guided therapy (n=275)
Number of subjects: 551
Study 29870855 — intervention group
Group type: COMPARATOR
Intervention: Standard diagnostic workup (control group, n=276)
Number of subjects: 551
Study 29870855 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT for confirmed bacterial infections
Number of subjects: 551
Study 29870855 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP for confirmed bacterial infections
Number of subjects: 551
Study 27075841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27075841 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 0
Study 27075841 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium + Olodaterol
Number of subjects: 0
Study 27075841 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium + Olodaterol + Exercise Training
Number of subjects: 0
Study 27075841 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 0
Study 24623067 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (10,000 IU day(‐1))
Number of subjects: 29
Study 24623067 — intervention group
Group type: COMPARATOR
Intervention: Placebo (visually identical)
Number of subjects: 29
Study 22541305 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) as an adjunct to eccentric exercises
Number of subjects: 40
Study 22541305 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment as an adjunct to eccentric exercises
Number of subjects: 40
Study 19074534 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (100 mg) with ethanol (0.6 per thousand)
Number of subjects: 16
Study 19074534 — intervention group
Group type: COMPARATOR
Intervention: MDMA (100 mg) alone
Number of subjects: 16
Study 19074534 — intervention group
Group type: COMPARATOR
Intervention: Ethanol (0.6 per thousand) alone
Number of subjects: 16
Study 17711566 — intervention group
Group type: EXPERIMENTAL
Intervention: remifentanil 1 microg/kg
Number of subjects: 164
Study 17711566 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil 10 microg/kg
Number of subjects: 164
Study 17711566 — intervention group
Group type: EXPERIMENTAL
Intervention: fentanyl 2 microg/kg
Number of subjects: 164
Study 17711566 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 164
Study 15124006 — intervention group
Group type: EXPERIMENTAL
Intervention: TPH2 gene SNP analysis in depressed patients
Number of subjects: 565
Study 15124006 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype analysis in depressed patients
Number of subjects: 565
Study 15124006 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 565
Study 12235444 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin alone
Number of subjects: 16
Study 12235444 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin with losartan
Number of subjects: 16
Study 12235444 — intervention group
Group type: COMPARATOR
Intervention: Losartan alone
Number of subjects: 16
Study 9832660 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person triage interviews conducted by certified ED triage nurses
Number of subjects: 0
Study 9832660 — intervention group
Group type: COMPARATOR
Intervention: Telephone triage interviews conducted by certified ED triage nurses
Number of subjects: 0
Study 9832660 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of complaint-based protocols in phase 2
Number of subjects: 0
Study 7859051 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide 2.5-5.0 mg
Number of subjects: 114
Study 7859051 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10-20 mg
Number of subjects: 114
Study 7859051 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide
Number of subjects: 114
Study 7859051 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 114
Study 2698934 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg twice a day)
Number of subjects: 66
Study 2698934 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone (25 mg once a day)
Number of subjects: 66
Study 2698934 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine + Chlorthalidone (both at the same doses)
Number of subjects: 66
Study 2698934 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 779554 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine sulfate 0.1 mg per kg
Number of subjects: 18
Study 779554 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 30768766 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily subcutaneous semaglutide
Number of subjects: 0
Study 30768766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30768766 — intervention group
Group type: COMPARATOR
Intervention: Once daily 3.0 mg liraglutide
Number of subjects: 0
Study 28034079 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib
Number of subjects: 232
Study 28034079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232
Study 25171889 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving therapy for primary care (PST-PC)
Number of subjects: 247
Study 25171889 — intervention group
Group type: COMPARATOR
Intervention: Coaching in healthy dietary practices (DIET)
Number of subjects: 247
Study 25171889 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PST-PC and DIET
Number of subjects: 247
Study 25171889 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher social problem-solving and physical functioning
Number of subjects: 247
Study 23756082 — intervention group
Group type: EXPERIMENTAL
Intervention: SWLP + MI
Number of subjects: 54
Study 23756082 — intervention group
Group type: COMPARATOR
Intervention: SWLP
Number of subjects: 54
Study 21763950 — intervention group
Group type: EXPERIMENTAL
Intervention: Mainstream schools
Number of subjects: 1158
Study 21763950 — intervention group
Group type: EXPERIMENTAL
Intervention: Special education centers
Number of subjects: 1158
Study 21763950 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prevalence
Number of subjects: 1158
Study 21763950 — intervention group
Group type: EXPERIMENTAL
Intervention: Most frequent diagnoses
Number of subjects: 1158
Study 19356905 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio‐Gide membrane
Number of subjects: 45
Study 19356905 — intervention group
Group type: EXPERIMENTAL
Intervention: Connective tissue graft
Number of subjects: 45
Study 19356905 — intervention group
Group type: EXPERIMENTAL
Intervention: Full‐thickness palatal mucosa graft
Number of subjects: 45
Study 16377062 — intervention group
Group type: EXPERIMENTAL
Intervention: r-FSH alone
Number of subjects: 40
Study 16377062 — intervention group
Group type: COMPARATOR
Intervention: r-FSH and r-LH
Number of subjects: 40
Study 15333274 — intervention group
Group type: EXPERIMENTAL
Intervention: Full questionnaire (General Health Questionnaire‐12, PTSD checklist, self-assessed health status, alcohol behaviour questions)
Number of subjects: 4500
Study 15333274 — intervention group
Group type: EXPERIMENTAL
Intervention: Abridged questionnaire (GHQ‐4, shortened PTSD checklist, fewer symptoms, no alcohol behaviour questions)
Number of subjects: 4500
Study 15333274 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen-positive individuals invited to attend a medical centre
Number of subjects: 4500
Study 15333274 — intervention group
Group type: COMPARATOR
Intervention: Servicemen with PTSD, alcohol behaviour, or multi-criteria 'screen-positive'
Number of subjects: 4500
Study 17290039 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone 500 microg, twice a day
Number of subjects: 108
Study 17290039 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 10365628 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Support Questionnaire (SSQ) administered to psychiatric patients
Number of subjects: 1547
Study 10365628 — intervention group
Group type: COMPARATOR
Intervention: Social Support Questionnaire (SSQ) administered to healthy controls
Number of subjects: 1547
Study 10365628 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Support Questionnaire (SSQ) for patients with anxiety disorder, mood disorder, schizophrenia, and V codes
Number of subjects: 1547
Study 10365628 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Support Questionnaire (SSQ) for schizophrenic patients
Number of subjects: 1547
Study 8896396 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF; 5 micrograms/kg) plus stem cell factor (SCF; 20 micrograms/kg) after chemotherapy
Number of subjects: 0
Study 8896396 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy and G-CSF alone
Number of subjects: 0
Study 1858035 — intervention group
Group type: EXPERIMENTAL
Intervention: Open file interview (290 candidates)
Number of subjects: 423
Study 1858035 — intervention group
Group type: COMPARATOR
Intervention: Blinded interview (133 candidates)
Number of subjects: 423
Study 7095850 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms of type 19F polysaccharide
Number of subjects: 0
Study 7095850 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms of type 19A polysaccharide
Number of subjects: 0
Study 7095850 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 micrograms of both polysaccharides premixed in a single injection
Number of subjects: 0
Study 7095850 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 19F polysaccharide antigen
Number of subjects: 0
Study 31774028 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 19
Study 31774028 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone
Number of subjects: 19
Study 31093657 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 694
Study 31093657 — intervention group
Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 694
Study 29347874 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (200 mg per day)
Number of subjects: 3800
Study 29347874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3800
Study 26775609 — intervention group
Group type: EXPERIMENTAL
Intervention: Drawing before dissection
Number of subjects: 416
Study 26775609 — intervention group
Group type: EXPERIMENTAL
Intervention: Drawing after dissection
Number of subjects: 416
Study 26775609 — intervention group
Group type: COMPARATOR
Intervention: No drawing (control group)
Number of subjects: 416
Study 25179916 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT-18 (1.2, 6, 18, 60, 180, 360, 540 mg)
Number of subjects: 28
Study 25179916 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT-18 (540 mg)
Number of subjects: 28
Study 25179916 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT-18 (180, 360, 540 mg)
Number of subjects: 28
Study 25179916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 22445946 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 523
Study 22445946 — intervention group
Group type: COMPARATOR
Intervention: Mood induction paradigm
Number of subjects: 523
Study 19181786 — intervention group
Group type: EXPERIMENTAL
Intervention: h‐ATG/CsA/sirolimus
Number of subjects: 77
Study 19181786 — intervention group
Group type: COMPARATOR
Intervention: h‐ATG/CsA
Number of subjects: 77
Study 17062764 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat (HF) diet (75% energy as fat)
Number of subjects: 10
Study 17062764 — intervention group
Group type: COMPARATOR
Intervention: Control diet (35% energy as fat)
Number of subjects: 10
Study 15646430 — intervention group
Group type: EXPERIMENTAL
Intervention: Dioctahedral smectite (3 g, three sachets, administered 1 h after meals for 28 days)
Number of subjects: 410
Study 15646430 — intervention group
Group type: COMPARATOR
Intervention: Probiotic preparation (Bifico 210 mg, two capsules for 28 days)
Number of subjects: 410
Study 15646430 — intervention group
Group type: EXPERIMENTAL
Intervention: Dioctahedral smectite
Number of subjects: 410
Study 15646430 — intervention group
Group type: COMPARATOR
Intervention: Probiotic preparation
Number of subjects: 410
Study 11825347 — intervention group
Group type: EXPERIMENTAL
Intervention: Postal questionnaires
Number of subjects: 315
Study 11825347 — intervention group
Group type: COMPARATOR
Intervention: Hospital records
Number of subjects: 315
Study 9541126 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (180 mmol fatty acids)
Number of subjects: 8
Study 9541126 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-chain triglycerides (180 mmol fatty acids)
Number of subjects: 8
Study 9541126 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-chain triglycerides (90 mmol fatty acids)
Number of subjects: 8
Study 9541126 — intervention group
Group type: COMPARATOR
Intervention: Sucrose polyester (90 mmol fatty acids)
Number of subjects: 8
Study 9541126 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 8
Study 7925518 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine (20 mg once daily, n = 16)
Number of subjects: 32
Study 7925518 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 16)
Number of subjects: 32
Study 2511299 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual dosage of lithium
Number of subjects: 0
Study 2511299 — intervention group
Group type: COMPARATOR
Intervention: Reduced lithium dosage by up to 50%
Number of subjects: 0
Study 30591410 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial Better Match (PBM) protocol
Number of subjects: 18
Study 30591410 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended Match (EM) protocol
Number of subjects: 18
Study 28645957 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing an e-cigarette advertisement
Number of subjects: 150
Study 28645957 — intervention group
Group type: COMPARATOR
Intervention: Neutral image
Number of subjects: 150
Study 28645957 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitudes towards e-cigarettes
Number of subjects: 150
Study 25561281 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Purification (BP) treatment
Number of subjects: 195
Study 25561281 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional therapy only)
Number of subjects: 195
Study 23116458 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.6 mg MSF
Number of subjects: 27
Study 23116458 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.2 mg MSF
Number of subjects: 27
Study 23116458 — intervention group
Group type: EXPERIMENTAL
Intervention: 10.8 mg MSF
Number of subjects: 27
Study 23116458 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 22011895 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% sodium hypochlorite (NaOCl)
Number of subjects: 5
Study 22011895 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Interporous (MI)
Number of subjects: 5
Study 22011895 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (DW)
Number of subjects: 5
Study 22011895 — intervention group
Group type: EXPERIMENTAL
Intervention: Periogard (PE)
Number of subjects: 5
Study 22011895 — intervention group
Group type: EXPERIMENTAL
Intervention: Cepacol (CE)
Number of subjects: 5
Study 22011895 — intervention group
Group type: EXPERIMENTAL
Intervention: Corega Tabs (CT)
Number of subjects: 5
Study 22011895 — intervention group
Group type: EXPERIMENTAL
Intervention: Polident (PO)
Number of subjects: 5
Study 19922132 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO) 40,000 units, administered fortnightly for 24 months
Number of subjects: 23
Study 19922132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 19922132 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO)
Number of subjects: 23
Study 16508590 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of olmesartan medoxomil once daily
Number of subjects: 4400
Study 16508590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4400
Study 12723832 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric sulfate pulpotomy (FS)
Number of subjects: 130
Study 12723832 — intervention group
Group type: COMPARATOR
Intervention: Root canal therapy (RCT)
Number of subjects: 130
Study 10661334 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy before or after irradiation (n = 40 before, n = 15 after)
Number of subjects: 55
Study 10661334 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete resection (n = 28)
Number of subjects: 55
Study 10661334 — intervention group
Group type: EXPERIMENTAL
Intervention: Incomplete resection (n = 27)
Number of subjects: 55
Study 10661334 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized tumors (no metastases at diagnosis)
Number of subjects: 55
Study 10661334 — intervention group
Group type: EXPERIMENTAL
Intervention: Metastatic tumors (presence of metastases at diagnosis)
Number of subjects: 55
Study 9339690 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole (up to 4.5 mg per day)
Number of subjects: 247
Study 9339690 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (30 mg per day)
Number of subjects: 247
Study 9339690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study 8348063 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinol, 25,000 international units/day
Number of subjects: 1029
Study 8348063 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene, 30 mg/day
Number of subjects: 1029
Study 8348063 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinol plus beta-carotene
Number of subjects: 1029
Study 8348063 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1029
Study 8348063 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 1029
Study 3521612 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg
Number of subjects: 70
Study 3521612 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 31785994 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP‐1
Number of subjects: 0
Study 31785994 — intervention group
Group type: COMPARATOR
Intervention: AGEs
Number of subjects: 0
Study 31785994 — intervention group
Group type: EXPERIMENTAL
Intervention: AGEs + GLP‐1
Number of subjects: 0
Study 29742937 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabecular‐titanium cup
Number of subjects: 38
Study 29742937 — intervention group
Group type: COMPARATOR
Intervention: Conventional acetabular component
Number of subjects: 38
Study 29742937 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (trabecular‐titanium and conventional)
Number of subjects: 38
Study 27277002 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone Patellar Tendon Bone (BPTB) graft
Number of subjects: 100
Study 27277002 — intervention group
Group type: COMPARATOR
Intervention: Hamstring graft
Number of subjects: 100
Study 25669003 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral spinal anesthesia (Group U)
Number of subjects: 40
Study 25669003 — intervention group
Group type: COMPARATOR
Intervention: Bilateral spinal anesthesia (Group B)
Number of subjects: 40
Study 24312194 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV‐DNA vaccine in addition to ongoing antiretroviral treatment (ART) (Group B)
Number of subjects: 20
Study 24312194 — intervention group
Group type: COMPARATOR
Intervention: Ongoing antiretroviral treatment (ART) (Group A)
Number of subjects: 20
Study 20167684 — intervention group
Group type: EXPERIMENTAL
Intervention: Median intradialytic BP
Number of subjects: 0
Study 20167684 — intervention group
Group type: COMPARATOR
Intervention: Pre1
Number of subjects: 0
Study 20167684 — intervention group
Group type: COMPARATOR
Intervention: Pre6
Number of subjects: 0
Study 20167684 — intervention group
Group type: EXPERIMENTAL
Intervention: Post1
Number of subjects: 0
Study 20167684 — intervention group
Group type: COMPARATOR
Intervention: Post6
Number of subjects: 0
Study 18432528 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose polyestradiol phosphate (PEP; Estradurin) 240 mg i.m. twice a month for 2 months and thereafter monthly
Number of subjects: 910
Study 18432528 — intervention group
Group type: COMPARATOR
Intervention: Combined androgen deprivation (CAD) with flutamide (Eulexin) 250 mg t.i.d. and triptorelin (Decapeptyl) 3.75 mg i.m. per month or bilateral orchidectomy
Number of subjects: 910
Study 16174986 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sinus surgery (ESS) for chronic sinusitis in patients with asthma
Number of subjects: 88